|
US1044508A
(en)
*
|
1911-04-21 |
1912-11-19 |
Ajax Forge Company |
Railway-frog.
|
|
BE789948A
(fr)
|
1971-10-13 |
1973-04-11 |
Sandoz Sa |
Nouveaux derives du pyrazole, leur preparation et leur application comme medicaments
|
|
JPS5113156B2
(cg-RX-API-DMAC7.html)
|
1972-10-21 |
1976-04-26 |
|
|
|
US4016037A
(en)
|
1975-10-15 |
1977-04-05 |
Ajinomoto Co., Inc. |
Method for producing L-amino acid
|
|
US4110536A
(en)
|
1977-04-18 |
1978-08-29 |
Miles Laboratories, Inc. |
Derivatives of 5-(indol-3-yl)hydantoin
|
|
DE2728523C2
(de)
|
1977-06-23 |
1986-02-27 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
4-Methyl-1,2,3-thiadiazol-5-carbonsäure-(cyclohexylmethyl)-amid, Mittel mit herbizider und wachstumsregulatorischer Wirkung enthaltend diese Verbindung sowie Verfahren zu seiner Herstellung
|
|
JPS55136279A
(en)
|
1979-04-09 |
1980-10-23 |
Ajinomoto Co Inc |
Preparation of tryptophan hydantoin
|
|
JPS5810074B2
(ja)
|
1979-07-18 |
1983-02-24 |
味の素株式会社 |
新規微生物
|
|
GB2080803B
(en)
|
1980-07-28 |
1984-01-18 |
Pfizer |
Hypoglycemic 5-substituted oxazolidine-2,4-diones
|
|
US4332952A
(en)
|
1980-07-28 |
1982-06-01 |
Pfizer Inc. |
Hypoglycemic 5-substituted oxazolidine-2,4-diones
|
|
DE3567460D1
(en)
|
1984-06-07 |
1989-02-16 |
Pfizer Ltd |
Dihydropyridines
|
|
JPS6122081A
(ja)
|
1984-07-10 |
1986-01-30 |
Mitsui Toatsu Chem Inc |
ヒダントイン化合物の製造法
|
|
US4684735A
(en)
|
1985-07-01 |
1987-08-04 |
Stauffer Chemical Company |
Promotion of raney nickel hydrogenation catalyst
|
|
JPH0623148B2
(ja)
|
1985-09-05 |
1994-03-30 |
三井東圧化学株式会社 |
Ｎ−アセチル−ｄｌ−アミノ酸の製造方法
|
|
DE3685626T2
(de)
|
1985-09-26 |
1993-01-28 |
Beckmann Research Inst Of The |
Sequenzierung von peptiden.
|
|
JPH0659227B2
(ja)
|
1985-11-08 |
1994-08-10 |
三井東圧化学株式会社 |
Ｄ−α−アミノ酸の製造方法
|
|
JPS6225990A
(ja)
|
1986-07-19 |
1987-02-03 |
Kanegafuchi Chem Ind Co Ltd |
Ｄ−α−アミノ酸類の製造方法
|
|
US4705864A
(en)
|
1986-11-10 |
1987-11-10 |
The Standard Oil Company |
Aryl oxime derivatives of hydantoins
|
|
US4911931A
(en)
|
1987-08-03 |
1990-03-27 |
Baylink David J |
Pharmaceutical combination for treatment of bone-wasting diseases
|
|
JP2661111B2
(ja)
|
1988-03-09 |
1997-10-08 |
三菱化学株式会社 |
Ｄ−Ｎ−カルバミル−α−アミノ酸の製造法
|
|
US4868061A
(en)
|
1988-05-19 |
1989-09-19 |
The Standard Oil Company |
Olefinic aryl oxime derivatives of hydantoins
|
|
IE62214B1
(en)
|
1988-05-25 |
1995-01-11 |
Warner Lambert Co |
Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
|
|
JPH0219363A
(ja)
|
1988-07-06 |
1990-01-23 |
Fujisawa Pharmaceut Co Ltd |
イミダゾリジン誘導体
|
|
WO1990004183A1
(en)
|
1988-10-07 |
1990-04-19 |
Commonwealth Scientific And Industrial Research Organisation |
Method for preparation of thiohydantoins and for protein sequence analysis
|
|
ATE94906T1
(de)
|
1989-01-02 |
1993-10-15 |
Ruetgerswerke Ag |
Verfahren zur herstellung von l-alphaaminos|uren.
|
|
JPH054910A
(ja)
|
1990-07-31 |
1993-01-14 |
Nikka Chem Co Ltd |
化粧料組成物
|
|
WO1992004045A1
(en)
|
1990-08-31 |
1992-03-19 |
Warner-Lambert Company |
Novel cholecystokinin antagonists, their preparation and therapeutic use
|
|
JP2651755B2
(ja)
|
1991-03-01 |
1997-09-10 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
|
NZ242065A
(en)
|
1991-03-26 |
1996-06-25 |
Csl Ltd |
Delayed release implant having a degradable or rupturable polymeric coating
|
|
US5693643A
(en)
|
1991-09-16 |
1997-12-02 |
Merck & Co., Inc. |
Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
|
|
DE69223573D1
(de)
|
1991-09-16 |
1998-01-29 |
Merck & Co Inc |
Hydantoin und Succinimid-substituierte Spiroindanylcamphorsulfonyl als Oxytocin-Antagonisten
|
|
CA2083891A1
(en)
|
1991-12-03 |
1993-06-04 |
Angus Murray Macleod |
Heterocyclic compounds, compositions containing them and their use in therapy
|
|
JP3163361B2
(ja)
|
1992-03-12 |
2001-05-08 |
味の素株式会社 |
５−アルキルヒダントイン誘導体の製造法
|
|
US5574030A
(en)
|
1992-07-14 |
1996-11-12 |
Nippon Chemiphar Co., Ltd. |
N-aminoalkyl-substituted nitrogen-containing five membered heterocyclic compounds
|
|
DK0579169T3
(da)
|
1992-07-14 |
1999-05-31 |
Nippon Chemiphar Co |
Alkylendiaminderivater
|
|
US5830854A
(en)
|
1992-12-14 |
1998-11-03 |
Merck Sharp & Dohme, Limited |
Method of treating cystic fibrosis using a tachykinin receptor antagonist
|
|
US5338859A
(en)
|
1993-02-12 |
1994-08-16 |
Hoechst Celanese Corporation |
Process for the production of calcium salts of hydantoic acids
|
|
EP0640594A1
(en)
|
1993-08-23 |
1995-03-01 |
Fujirebio Inc. |
Hydantoin derivative as metalloprotease inhibitor
|
|
CA2199508A1
(en)
|
1994-09-08 |
1996-03-14 |
Darryle Darwin Schoepp |
Excitatory amino acid receptor antagonists
|
|
WO1996030393A1
(en)
|
1995-03-27 |
1996-10-03 |
Warner-Lambert Company |
A method for the synthesis of mixtures of compounds
|
|
US6166054A
(en)
|
1995-03-31 |
2000-12-26 |
Nihon Nohyaku Co., Ltd. |
Agricultural and horticultural disease controller and a method for controlling the diseases
|
|
US5674734A
(en)
|
1995-05-18 |
1997-10-07 |
President And Fellows Of Harvard College |
Cell death protein
|
|
DE19519717C1
(de)
|
1995-05-30 |
1996-08-22 |
Degussa |
Neuer Mikroorganismus, dessen Verwendung und Verfahren zur Herstellung von L-alpha-Aminosäuren
|
|
US6846839B1
(en)
|
1995-06-07 |
2005-01-25 |
Sugen, Inc. |
Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis
|
|
US5962478A
(en)
|
1995-09-19 |
1999-10-05 |
Margolin; Solomon B. |
Inhibition of tumor necrosis factor α
|
|
WO1997015586A1
(en)
|
1995-10-23 |
1997-05-01 |
Tularik, Inc. |
Rip: novel human protein involved in tumor necrosis factor signal transduction, and screening assays
|
|
CA2252761A1
(en)
|
1996-04-24 |
1997-10-30 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
DE69722019T2
(de)
|
1996-09-30 |
2003-11-27 |
Nihon Nohyaku Co., Ltd. |
1,2,3-thiadiazol-derivate und ihre salze, mittel zur kontrolle von krankheiten in landwirtschaft und gartenbau und eine methode zu ihrer anwendung
|
|
US5859190A
(en)
|
1997-02-04 |
1999-01-12 |
Trega Biosciences, Inc. |
Combinatorial libraries of hydantoin and thiohydantoin derivatives, methods of making the libraries and compounds therein
|
|
CN1249748A
(zh)
|
1997-03-03 |
2000-04-05 |
贝林格尔·英格海姆药物公司 |
用于治疗炎症疾病的小分子
|
|
IL126024A0
(en)
|
1998-03-19 |
1999-05-09 |
Yeda Res & Dev |
Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
|
|
EP0976326B1
(en)
|
1998-07-30 |
2003-05-02 |
Nihon Nohyaku Co., Ltd. |
Fungicidal composition containing a 1,2,3-tiadiazole derivative and its use
|
|
DE19940211A1
(de)
|
1998-09-22 |
2000-03-23 |
Degussa |
Verfahren zur Herstellung von Imidazolidin-2,4-dionen
|
|
US6020198A
(en)
|
1998-09-25 |
2000-02-01 |
Isis Pharmaceuticals Inc. |
Antisense modulation of RIP-1 expression
|
|
AU754989B2
(en)
|
1998-11-16 |
2002-11-28 |
Nippon Zoki Pharmaceutical Co., Ltd. |
A therapeutic agent for intractable vasculitis
|
|
WO2001007044A1
(en)
|
1999-07-21 |
2001-02-01 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
|
WO2001007048A1
(en)
|
1999-07-21 |
2001-02-01 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
|
WO2001028493A2
(en)
|
1999-10-15 |
2001-04-26 |
President And Fellows Of Harvard College |
Small molecule inhibitors of necrosis
|
|
US6756394B1
(en)
|
1999-10-15 |
2004-06-29 |
President And Fellow Of Harvard College |
Small molecule inhibitors of necrosis
|
|
US6706766B2
(en)
|
1999-12-13 |
2004-03-16 |
President And Fellows Of Harvard College |
Small molecules used to increase cell death
|
|
US20030087949A1
(en)
|
2000-03-30 |
2003-05-08 |
Mikiko Sodeoka |
Indolylpyrrole derivatives and cell death inhibitors
|
|
US20020155172A1
(en)
|
2000-04-07 |
2002-10-24 |
Junying Yuan |
Methods and compounds for decreasing cell toxicity or death
|
|
GB0011071D0
(en)
|
2000-05-08 |
2000-06-28 |
Novartis Ag |
Organic compounds
|
|
US6846643B2
(en)
|
2000-08-14 |
2005-01-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy
|
|
US20020064736A1
(en)
|
2000-09-27 |
2002-05-30 |
Fuji Photo Film Co., Ltd. |
Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye
|
|
JP2002145192A
(ja)
|
2000-11-07 |
2002-05-22 |
Yamaha Motor Co Ltd |
水上乗物の燃料タンク構造
|
|
JP4529338B2
(ja)
|
2001-03-08 |
2010-08-25 |
味の素株式会社 |
ヒダントイナーゼをコードするｄｎａ、ｎ−カルバミル−ｌ−アミノ酸ハイドロラーゼをコードするｄｎａ、組み換えｄｎａ、形質転換された細胞、タンパク質の製造方法および光学活性アミノ酸の製造方法
|
|
WO2003027081A2
(en)
|
2001-09-14 |
2003-04-03 |
Novo Nordisk A/S |
NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER
|
|
US20040019092A1
(en)
|
2001-11-14 |
2004-01-29 |
Daniel Berney |
Non-peptide somatostatin receptor ligands
|
|
IL161940A0
(en)
|
2001-11-22 |
2005-11-20 |
Ono Pharmaceutical Co |
Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
|
|
US6797708B2
(en)
|
2001-12-03 |
2004-09-28 |
Wyeth |
Inhibitors of cytosolic phospholipase A2
|
|
JP3659224B2
(ja)
|
2001-12-26 |
2005-06-15 |
村田機械株式会社 |
インターネットファクシミリ装置
|
|
AU2002359359A1
(en)
|
2001-12-28 |
2003-07-24 |
Somatocor Pharmaceuticals, Inc. |
Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
|
|
AU2003215077A1
(en)
|
2002-02-11 |
2003-09-04 |
Wyeth |
Solution structure of rip dd and uses therof
|
|
CA2497880A1
(en)
|
2002-09-06 |
2004-03-18 |
Mount Sinai Hospital |
Methods for assaying protein-protein interactions
|
|
AU2003293124A1
(en)
|
2002-11-27 |
2004-06-23 |
Artesian Therapeutics, Inc. |
Heart failure gene determination and therapeutic screening
|
|
AU2003291972A1
(en)
|
2002-12-20 |
2004-07-14 |
Novo Nordisk A/S |
Pharmaceutical compositions comprising insulin and legends of insulin hexamer
|
|
FR2850652B1
(fr)
|
2003-01-31 |
2008-05-30 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
GB0302671D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
|
US7320986B2
(en)
|
2003-03-07 |
2008-01-22 |
Abbott Labortories |
Fused tri and tetra-cyclic pyrazole kinase inhibitors
|
|
BRPI0408229A
(pt)
|
2003-03-11 |
2006-02-21 |
Novo Nordisk As |
preparação farmacêutica, métodos para preparar um ligando de ligação de zinco, para prolongar a ação de uma preparação de insulina estabilizada por ácido e para tratar diabete do tipo 1 ou tipo 2, e, uso de uma preparação
|
|
WO2004080481A1
(en)
|
2003-03-13 |
2004-09-23 |
Novo Nordisk A/S |
Novel nph insulin preparations
|
|
ES2567135T3
(es)
|
2003-08-29 |
2016-04-20 |
The Brigham And Women's Hospital, Inc. |
Derivados de hidantoína como inhibidores de necrosis celular
|
|
JP4452914B2
(ja)
|
2003-09-08 |
2010-04-21 |
味の素株式会社 |
新規トランスポータタンパク質
|
|
WO2005028664A2
(en)
|
2003-09-17 |
2005-03-31 |
University Of Massachusetts |
Modulation of programmed necrosis
|
|
DE10342839A1
(de)
|
2003-09-17 |
2005-04-28 |
Symrise Gmbh & Co Kg |
Thiohydantoine zur Aufhellung von Haut oder Haar
|
|
US6887993B1
(en)
|
2003-11-12 |
2005-05-03 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
|
EP1720857B1
(en)
|
2004-02-19 |
2011-07-13 |
Bayer Schering Pharma Aktiengesellschaft |
Dihydropyridinone derivatives
|
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
GB0410379D0
(en)
|
2004-05-11 |
2004-06-16 |
Univ Leicester |
Treatment of cancer
|
|
SG155188A1
(en)
|
2004-07-30 |
2009-09-30 |
Exelixis Inc |
Pyrrole derivatives as pharmaceutical agents
|
|
CA2594662A1
(en)
|
2005-02-10 |
2006-08-17 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
WO2006103995A1
(ja)
|
2005-03-25 |
2006-10-05 |
Kaneka Corporation |
光学活性α－アミノ酸誘導体の製造方法
|
|
RU2008110908A
(ru)
|
2005-08-25 |
2009-09-27 |
Шеринг Корпорейшн (US) |
Производные имидазола в качестве функционально селективных агонистов альфа2с адренорецепторов
|
|
CN101304976A
(zh)
|
2005-10-11 |
2008-11-12 |
因特蒙公司 |
病毒复制抑制剂
|
|
JP2009518286A
(ja)
|
2005-11-01 |
2009-05-07 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
グルコキナーゼのアロステリックモジュレーターとしてのジヒドロイソインドロン
|
|
AU2006331754B9
(en)
|
2005-12-20 |
2013-07-11 |
President And Fellows Of Harvard College |
Compounds, screens, and methods of treatment
|
|
AR056882A1
(es)
|
2006-02-01 |
2007-10-31 |
Bayer Cropscience Sa |
Derivados del fungicida n- cicloalquil- bencil- amida
|
|
US8007790B2
(en)
|
2006-04-03 |
2011-08-30 |
Stowers Institute For Medical Research |
Methods for treating polycystic kidney disease (PKD) or other cyst forming diseases
|
|
CA2658223A1
(en)
|
2006-07-13 |
2008-01-17 |
4Sc Ag |
Benzopyranopyrazoles
|
|
AU2007307044B2
(en)
|
2006-10-10 |
2014-03-20 |
President And Fellows Of Harvard College |
Compounds, screens, and methods of treatment
|
|
WO2008148755A2
(en)
|
2007-06-06 |
2008-12-11 |
Dsm Ip Assets B.V. |
Novel 5-substituted hydantoins
|
|
EP3034494A1
(en)
|
2007-08-15 |
2016-06-22 |
President and Fellows of Harvard College |
Heterocyclic inhibitors of necroptosis
|
|
EP2234608A2
(en)
|
2007-12-11 |
2010-10-06 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
|
CA2714183A1
(en)
|
2008-02-14 |
2009-08-20 |
F. Hoffmann-La Roche Ag |
Prediction of bone marrow toxicity
|
|
US20120061324A1
(en)
*
|
2008-03-28 |
2012-03-15 |
Global Material Technologies, Inc. |
Element removal process and apparatus
|
|
US8304421B2
(en)
|
2008-09-30 |
2012-11-06 |
Vanderbilt University |
Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agents
|
|
WO2010075290A1
(en)
|
2008-12-22 |
2010-07-01 |
President And Fellows Of Harvard College |
Unsaturated heterocyclic inhibitors of necroptosis
|
|
EP2381775A4
(en)
|
2008-12-23 |
2012-08-15 |
Harvard College |
INHIBITORS OF NECROPTOSIS OF SMALL MOLECULAR SIZE
|
|
JP2010202575A
(ja)
|
2009-03-03 |
2010-09-16 |
Takeda Chem Ind Ltd |
複素環化合物
|
|
DE102009002044A1
(de)
|
2009-03-31 |
2010-10-07 |
Evonik Degussa Gmbh |
Dipeptide als Futtermitteladditive
|
|
JP5332882B2
(ja)
|
2009-04-30 |
2013-11-06 |
豊田合成株式会社 |
半導体発光素子
|
|
JP2010275229A
(ja)
|
2009-05-28 |
2010-12-09 |
Ikutoku Gakuen |
ヒダントイン誘導体
|
|
CA2784807C
(en)
|
2009-12-29 |
2021-12-14 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
|
AR080234A1
(es)
|
2010-02-25 |
2012-03-21 |
Marrone Bio Innovations Inc |
Cepa bacteriana aislada del genero burkholderia y metabolitos pesticidas del mismo
|
|
AU2011227643A1
(en)
|
2010-03-16 |
2012-09-20 |
Dana-Farber Cancer Institute, Inc. |
Indazole compounds and their uses
|
|
WO2011123609A1
(en)
|
2010-03-31 |
2011-10-06 |
Glaxo Group Limited |
Imidazolyl-imidazoles as kinase inhibitors
|
|
AU2011242465B2
(en)
|
2010-04-23 |
2017-01-19 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
|
US20140024598A1
(en)
|
2010-11-01 |
2014-01-23 |
Demetrios Vavvas |
Methods and compositions for preserving retinal ganglion cells
|
|
EP2683387A4
(en)
|
2011-03-07 |
2014-09-03 |
Univ Ohio State |
MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (miR-155) LINKS INFLAMMATION AND CANCER
|
|
EP2707714B1
(en)
|
2011-05-09 |
2019-10-09 |
Whitehead Institute For Biomedical Research |
Chaperone interaction assays and uses thereof
|
|
CN102850252B
(zh)
|
2011-06-30 |
2014-08-13 |
山东大学 |
一种3,5,5’-三取代乙内酰脲的制备方法
|
|
WO2013013826A1
(en)
|
2011-07-27 |
2013-01-31 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Necroptosis inhibitors for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
US9314328B2
(en)
|
2011-08-16 |
2016-04-19 |
W. L. Gore & Associates, Inc. |
Branched stent graft device and deployment
|
|
JP5961693B2
(ja)
|
2011-08-27 |
2016-08-02 |
マローネ バイオ イノベーションズ，インコーポレイテッド |
ブルクホルデリア（Ｂｕｒｋｈｏｌｄｅｒｉａ）属の単離細菌株及びそれに由来する殺有害生物性代謝物の製剤及び使用
|
|
CA2888805C
(en)
*
|
2011-10-21 |
2020-07-14 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for promoting axon regeneration and nerve function
|
|
US8492556B2
(en)
|
2011-11-10 |
2013-07-23 |
Allergan, Inc. |
2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
|
|
US9353419B2
(en)
|
2012-05-04 |
2016-05-31 |
Novartis Ag |
Biomarkers for IAP inhibitor therapy
|
|
US20150202250A1
(en)
|
2012-06-26 |
2015-07-23 |
Biovalence Sdn. Bhd. |
Anticancer treatment
|
|
US20150185215A1
(en)
|
2012-07-02 |
2015-07-02 |
Cell Assay Innovations, Inc. |
Cell-Based Assays For Post-Translational Enzyme Activity
|
|
JPWO2014126127A1
(ja)
|
2013-02-13 |
2017-02-02 |
国立大学法人北海道大学 |
ネクロプトーシス関連疾患の治療用医薬組成物及びその有効成分のスクリーニング方法
|
|
TWI648273B
(zh)
|
2013-02-15 |
2019-01-21 |
英商葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之雜環醯胺類（三）
|
|
EP2961849A2
(en)
|
2013-02-27 |
2016-01-06 |
The Broad Institute, Inc. |
T cell balance gene expression, compositions of matters and methods of use thereof
|
|
JP2016514693A
(ja)
|
2013-03-15 |
2016-05-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ハイブリッド型ネクロトーシス阻害剤
|
|
WO2014152182A1
(en)
|
2013-03-15 |
2014-09-25 |
President And Fellows Of Harvard College |
Deuterated heterocyclic inhibitors of necroptosis
|
|
EP2976331B1
(en)
|
2013-03-21 |
2017-03-01 |
Sanofi-Aventis Deutschland GmbH |
Synthesis of hydantoin containing peptide products
|
|
WO2014170892A1
(en)
|
2013-04-15 |
2014-10-23 |
Yeda Research And Development Co. Ltd. |
Inhibition of rip kinases for treating lysosomal storage diseases
|
|
GB201316651D0
(en)
|
2013-09-19 |
2013-11-06 |
Univ Southampton |
Asthma
|
|
WO2015039705A1
(en)
|
2013-09-23 |
2015-03-26 |
Carl Zeiss Smt Gmbh |
Multilayer mirror
|
|
EP2857839A1
(en)
|
2013-10-01 |
2015-04-08 |
AIT Austrian Institute of Technology GmbH |
Breast cancer diagnostic method and means
|
|
WO2015077709A2
(en)
|
2013-11-22 |
2015-05-28 |
World Biotechnology LLC |
Method for harvesting organic compounds from genetically modified organisms
|
|
WO2015095449A1
(en)
|
2013-12-19 |
2015-06-25 |
Ptc Therapeutics, Inc. |
Methods for modulating the amount rna transcripts
|
|
EP3082820B1
(en)
|
2013-12-19 |
2022-07-20 |
PTC Therapeutics, Inc. |
Methods for modulating the amount of rna transcripts
|
|
WO2015105938A1
(en)
|
2014-01-08 |
2015-07-16 |
World Biotechnology LLC |
Genetically modified organisms to produce organic compounds
|
|
WO2015154197A1
(en)
|
2014-04-11 |
2015-10-15 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Compositions and methods for glioblastoma treatment
|
|
JP2017526670A
(ja)
|
2014-08-13 |
2017-09-14 |
マックス−プランク−ゲゼルシャフト ツール フェルデルンク デル ヴィッセンシャフテン エー．ファウ． |
ネクロトーシス（ｎｅｃｒｏｐｔｏｓｉｓ）の阻害による腫瘍転移の阻止
|
|
WO2016025129A1
(en)
|
2014-08-14 |
2016-02-18 |
Alhamadsheh Mamoun M |
Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life
|
|
WO2016044777A1
(en)
|
2014-09-18 |
2016-03-24 |
Abbvie Inc. |
Hat inhibitors and methods for their use
|
|
EP3017825A1
(en)
|
2014-11-06 |
2016-05-11 |
Ludwig-Maximilians-Universität München |
An inhibitor of the RIPK1-dependent necrosis pathway and a pharmaceutical composition comprising the same
|
|
AU2015360291A1
(en)
|
2014-12-11 |
2017-07-13 |
President And Fellows Of Harvard College |
Inhibitors of cellular necrosis and related methods
|
|
CN107108467B
(zh)
|
2014-12-24 |
2022-08-19 |
北京生命科学研究所 |
细胞坏死抑制剂
|
|
CN107108492B
(zh)
|
2014-12-24 |
2021-03-19 |
北京生命科学研究所 |
细胞坏死抑制剂
|